SAVED
File name .JPG
File alt. text
Image should be px wide x px tall.
Select Image
home - Miscellaneous - Infection - GI AIDS Written by Dr Sebastian Zeki

GI AIDS

RUQP/fever/malaise Very raised ALP with normal bilirubin On ERCP - Papillary stenosis - Intrahepatic sclerosing cholangitis Causes -Cryptosporidium Microsporidia CMV MAC Cyclospora NHL Kaposi's Diagnosed by brush duodenal mucosa Cryptospordia (severe, most common) - swimming pools/lakes Microsporidia ("Merant inclusions") Giardia Viruses Causes: Pentamidine, DDI, DDC CMV, HSV, LAC, TB (needs pancreatic biopsy - difficult) Hepatic conditions: Granulomatous hepatitis. Micro/macro vesicular hepatosteatosis. Diffuse hepatocellular injury. Sclerosing cholangitis. Shigella Salmonella Campylobacter C. diff. CMV (in 40% in Wrights: only) Treat with Valganciclovir/Adofavir/Phoscarnet/Ganciclovir - Pathogen found in 50 to 85% of AIDS diarrhoea regardless of CD-4 - If shigella, salmonella or campylobacter nega-tive then for endoscopy. Cause: Bartonella - multiple liver cysts Treatment: Doxycycline/Erythromycin Clinical presentation: fever, weight loss, abdominal pain, reddish skin papules Viral: CMV/HSV (volcano crater ulcers)/EBV Fungal: histoplasmosis, cryptococcus Bacterial: MAI, TB, Nocardia, Actinomyces Tumours: NHL, Kaposi's, cancer, lymphoma Drugs: HAART Idiopathic With oesophageal problems give empirical candida treatment If doesn't resolve quickly then for OGD GI tract and AIDS AIDS cholangiopathy Biliary peliosis hepatitis (BPH) Enteritis: MCC Colitis Pancreatitis Oesophageal ulceration Written by Dr Sebastian Zeki

Related Stories

Global trends in norovirus genotype distribution among medically attended children with acute gastroenteritis, 2020-2025

Spatiotemporal clusters and dengue hotspots in the Philippines: a nationwide analysis spanning 2017-2024

Nationwide Analysis of Eosinophilic Granulomatosis With Polyangiitis Hospitalizations

Subject: submission of manuscript entitled "integrating eTEP ventral hernia repair into bariatric surgery: technical insights and clinical outcomes from an institutional experience"

PRV-delgE/gI/TK immunization preserves blood-brain barrier integrity and limits CNS injury following intracerebral PRV challenge